By use of DNA DSB markers γH2AX and 53BP1, gamma-ray induced DSBs in peripheral blood lymphocytes of prostate cancer patients undergoing brachytherapy with 125I seeds can be readily visualised and quantified. This evidence concerns the gene TP53BP1 and prostate cancer.